← Back to directoryWukong Health Navigator · Cardiology
Internal Medicine · 内科
Cardiology心血管内科 · Cardiología
Live now
Choose your specialist
This specialty has several focused companions, each anchored on its own world-leading clinicians and 2021–2026 evidence. Not sure which one? Start with the generalist and it will point you to the right specialist.
General
Not sure? Start hereAtrial fibrillationAtrial fibrillationCatheter ablationAnticoagulation
Dr. Hugh CalkinsJohns Hopkins MedicineAuthored the HRS AFib guidelines; established ablation practice
Dr. Jonathan P. PicciniDuke University · Duke Clinical Research InstituteAdvanced pulsed-field ablation to first-line AFib therapy
Ischemic heart diseaseIschemic heart diseaseAcute coronary syndromeAntiplatelet therapy
Dr. Eugene BraunwaldBrigham & Women's · TIMI Study GroupCreated the pre-test-probability framework for chest pain
Dr. Robert P. GiuglianoBrigham & Women's · TIMI Study GroupTIMI investigator — defined hs-troponin NSTE-ACS stratification
Dr. Roxana MehranMount Sinai · Icahn School of MedicinePrincipal investigator of TWILIGHT — bleeding-vs-ischemic balance
Heart failureHeart failureGDMT pillarsHFpEF
Dr. Scott D. SolomonBrigham & Women's · Harvard MedLed PARADIGM-HF and EMPEROR-Preserved — reshaped HFpEF therapy
Dr. Milton PackerBaylor University Medical CenterLed DAPA-HF and EMPEROR-Reduced — established SGLT2i in HF
HypertensionHypertensionResistant HTNRenal denervation
Dr. John W. McEvoyRCSI · ESC 2024 Guideline ChairChaired the 2024 ESC Hypertension Guideline
Dr. Rhian M. TouyzMcGill University · ESC 2024 Co-ChairCo-chaired the 2024 ESC guideline; vascular biology of HTN
Lipid managementLipid managementPrimary preventionLp(a)
Dr. Marc S. SabatineBrigham & Women's · TIMI Study GroupLed FOURIER and ODYSSEY OUTCOMES — opened the PCSK9 era
Dr. Valentin FusterMount Sinai HeartBuilt the three-axis model of atherosclerosis progression
Valvular heart diseaseValvular heart diseaseTAVRMitral interventions
Dr. Catherine M. OttoUniversity of WashingtonLead author of the AHA/ACC Valvular Heart Disease guidelines
Dr. Michael J. MackBaylor Scott & White HealthLed PARTNER 3 — brought TAVR to low-risk patients
Dr. Martin B. LeonColumbia University · NewYork-PresbyterianTAVR pioneer; first author of PARTNER 3 7-year follow-up
This agent is trained only on publicly available medical literature and educational materials. It does not provide individualized medical advice, diagnosis, or prescription. Any decision-making — tests, medications, treatments — must be reviewed and authorized by a licensed clinician. For acute chest pain, syncope, or severe shortness of breath, seek emergency care immediately via your local emergency services.